Acute Kidney Injury in a Patient with Nephrotic Syndrome due to Focal Segmental Glomerular Nephritis Induced by a Single Oral Administration of High-dose Bisphosphonate (Minodronate)-Reference-Cited by-同舟云学术

Acute Kidney Injury in a Patient with Nephrotic Syndrome due to Focal Segmental Glomerular Nephritis Induced by a Single Oral Administration of High-dose Bisphosphonate (Minodronate)

Published:2013 Issue:12 Volume:52 Page:1383-1387
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Komada Takanori¹,Morishita Yoshiyuki¹,Kitamura Masafumi¹,Iwazu Kana¹,Numata Akihiko¹,Kobayashi Takahisa¹,Yamamoto Hisashi¹,Akimoto Tetsu¹,Saito Osamu¹,Ando Yasuhiro¹,Takemoto Fumi¹,Muto Shigeaki¹,Yumura Wako¹,Kusano Eiji¹

Affiliation:

1. Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/52/12/52_52.0094/_pdf

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-induced glomerular diseases;Therapies;2023-10

2. Podocyte Geranylgeranyl Transferase Type-I Is Essential for Maintenance of the Glomerular Filtration Barrier;Journal of the American Society of Nephrology;2023-01-13

3. Nephrotic syndrome with acute kidney injury due to focal segmental glomerulosclerosis following long-term treatment with minodronate;CEN Case Reports;2021-08-28

4. Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study;Health Technology Assessment;2021-03

5. Minodronate for the treatment of osteoporosis;Therapeutics and Clinical Risk Management;2018-04